BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang X, Li M, Xi H, Zhang R, Chen J, Zhang Y, Xu X. Pre-existing mutations related to tenofovir in chronic hepatitis B patients with long-term nucleos(t)ide analogue drugs treatment by ultra-deep pyrosequencing. Oncotarget. 2016;7:70264-70275. [PMID: 27602500 DOI: 10.18632/oncotarget.11840] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Goto A, Rodriguez-Esteban R, Scharf SH, Morris GM. Understanding the genetics of viral drug resistance by integrating clinical data and mining of the scientific literature. Sci Rep 2022;12:14476. [PMID: 36008431 DOI: 10.1038/s41598-022-17746-3] [Reference Citation Analysis]
2 Goto A, Rodriguez-esteban R, Scharf SH, Morris GM. Understanding the Genetics of Viral Drug Resistance by Integrating Clinical Data and Mining of the Scientific Literature.. [DOI: 10.1101/2021.10.26.465417] [Reference Citation Analysis]
3 Qian F, Zou W, Jin F, Li D, Shen Y. Prevalence of Potential Resistance Related Variants Among Chinese Chronic Hepatitis B Patients Not Receiving Nucleos(T)ide Analogues. Infect Drug Resist 2020;13:2407-16. [PMID: 32765014 DOI: 10.2147/IDR.S249476] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Park ES, Lee AR, Kim DH, Lee JH, Yoo JJ, Ahn SH, Sim H, Park S, Kang HS, Won J, Ha YN, Shin GC, Kwon SY, Park YK, Choi BS, Lee YB, Jeong N, An Y, Ju YS, Yu SJ, Chae HB, Yu KS, Kim YJ, Yoon JH, Zoulim F, Kim KH. Identification of a quadruple mutation that confers tenofovir resistance in chronic hepatitis B patients. J Hepatol 2019;70:1093-102. [PMID: 30794889 DOI: 10.1016/j.jhep.2019.02.006] [Cited by in Crossref: 94] [Cited by in F6Publishing: 93] [Article Influence: 23.5] [Reference Citation Analysis]
5 Choi YM, Lee SY, Kim BJ. Naturally occurring hepatitis B virus reverse transcriptase mutations related to potential antiviral drug resistance and liver disease progression. World J Gastroenterol 2018; 24(16): 1708-1724 [PMID: 29713126 DOI: 10.3748/wjg.v24.i16.1708] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
6 Rajoriya N, Combet C, Zoulim F, Janssen HLA. How viral genetic variants and genotypes influence disease and treatment outcome of chronic hepatitis B. Time for an individualised approach? J Hepatol 2017;67:1281-97. [PMID: 28736138 DOI: 10.1016/j.jhep.2017.07.011] [Cited by in Crossref: 98] [Cited by in F6Publishing: 97] [Article Influence: 16.3] [Reference Citation Analysis]
7 Adefovir/entecavir. Reactions Weekly 2017;1633:26-26. [DOI: 10.1007/s40278-017-24297-4] [Reference Citation Analysis]